NIAID Announces Plan to Battle Leading Killer Diseases – National Institute of Allergy and Infectious Diseases plans to battle HIV infection, malaria, and tuberculosis
The National Institute of Allergy and Infectious Diseases (NIAID) recently introduced a global plan to combat three leading infectious killers: human immunodeficiency virus (HIV), malaria and tuberculosis. The NIAID plan focuses on four key research areas: vaccine and prevention studies, drug development, diagnostics and enhancements to research and treatment facilities within endemic areas. Vaccine research will be the top priority and, although a vaccine currently exists for tuberculosis, it does not prevent the adult lung disease that affects much of the world’s population. Drug development will concentrate on new drugs to combat drug-resistant microbe strains for each disease and on reducing the toxic side effects of many existing medications, particularly those used to treat HIV infection. Improved diagnostics will ensure more rapid and accurate identification of disease. A copy of the “NIAID Global Health Research Plan for HIV/AIDS, Malaria and Tuberculosis” can be found online at http://www. niaid.nih.gov/publications/globalhealth/global.pdf.
COPYRIGHT 2001 American Academy of Family Physicians
COPYRIGHT 2001 Gale Group